Scarica l'app Stockscreener
12.39
0.32%
0.04
Dopo l'orario di chiusura:
12.47
0.08
+0.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.35
Aprire:
$12.4
Volume 24 ore:
1.36M
Relative Volume:
0.69
Capitalizzazione di mercato:
$837.19M
Reddito:
$796.00M
Utile/perdita netta:
$-136.49M
Rapporto P/E:
-5.9282
EPS:
-2.09
Flusso di cassa netto:
$-64.24M
1 W Prestazione:
+5.09%
1M Prestazione:
-19.65%
6M Prestazione:
-36.43%
1 anno Prestazione:
-69.87%
Intervallo 1D:
$11.88
$12.50
Intervallo di 1 settimana:
$11.83
$13.10
Portata 52W:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Nome
Tandem Diabetes Care Inc
Settore
Industria
Telefono
858-366-6900
Indirizzo
12400 HIGH BLUFF DRIVE, San Diego, CA
Confronta TNDM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.39 | 863.54M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Downgrade | Citigroup | Neutral → Sell |
| 2025-06-16 | Iniziato | Truist | Hold |
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2025-03-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-03-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-10-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Aggiornamento | Stifel | Hold → Buy |
| 2023-08-04 | Downgrade | Citigroup | Buy → Neutral |
| 2023-05-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-08-09 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Iniziato | Wells Fargo | Overweight |
| 2020-07-31 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-18 | Reiterato | Raymond James | Outperform |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-06 | Iniziato | Raymond James | Outperform |
| 2020-02-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Iniziato | Guggenheim | Buy |
| 2019-10-04 | Aggiornamento | UBS | Neutral → Buy |
| 2019-05-17 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-13 | Iniziato | SVB Leerink | Outperform |
| 2019-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2019-03-05 | Reiterato | BofA/Merrill | Neutral |
| 2019-02-27 | Reiterato | Lake Street | Buy |
| 2018-11-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Reiterato | Dougherty & Company | Buy |
| 2018-09-26 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Is Tandem Diabetes Care Inc. a strong candidate for buy and hold2025 Technical Patterns & Smart Swing Trading Alerts - khodrobank.com
Should you wait for a breakout in Tandem Diabetes Care Inc.July 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Is now a turning point for Tandem Diabetes Care Inc.Stop Loss & High Conviction Investment Ideas - Newser
Analyzing recovery setups for Tandem Diabetes Care Inc. investorsTrade Volume Report & Weekly Setup with ROI Potential - Newser
What Fibonacci levels say about Tandem Diabetes Care Inc. reboundJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
Combining price and volume data for Tandem Diabetes Care Inc.Risk Management & Real-Time Chart Breakout Alerts - Newser
How to escape a deep drawdown in Tandem Diabetes Care Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - Newser
Backtesting results for Tandem Diabetes Care Inc. trading strategiesJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Using Ichimoku Cloud for Tandem Diabetes Care Inc. technicalsJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
How to read the order book for Tandem Diabetes Care Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - Newser
What to expect from Tandem Diabetes Care Inc. in the next 30 daysJobs Report & Precise Swing Trade Alerts - Newser
Published on: 2025-09-03 02:48:30 - Newser
How high can Tandem Diabetes Care Inc. stock go2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Sector ETF performance correlation with Tandem Diabetes Care Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
Why Tandem Diabetes Care Inc. is moving todayInsider Selling & Free Daily Entry Point Trade Alerts - Newser
What is Tandem Diabetes Care Inc.’s valuation compared to sectorWeekly Stock Summary & Precise Entry and Exit Recommendations - khodrobank.com
Long term hold vs stop loss in Tandem Diabetes Care Inc.July 2025 Short Interest & AI Driven Stock Reports - Newser
Tick level data insight on Tandem Diabetes Care Inc. volatilityTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Published on: 2025-09-02 05:08:07 - Newser
What is the earnings history of Tandem Diabetes Care Inc.2025 Volume Leaders & Growth-Oriented Investment Plans - خودرو بانک
Is Tandem Diabetes Care Inc. stock a smart retirement pick2025 Buyback Activity & Long-Term Growth Portfolio Plans - khodrobank.com
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - MSN
Can Tandem Diabetes Care Inc. generate free cash flowJuly 2025 Summary & Expert-Curated Trade Recommendations - خودرو بانک
Is Tandem Diabetes Care Inc. a speculative investmentMarket Volume Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Investigation Underway: Tandem Diabetes Care, Inc. (TNDM)Contact Levi & Korsinsky Over Securities Law Violations - ACCESS Newswire
News impact scoring models applied to Tandem Diabetes Care Inc.July 2025 Levels & Real-Time Stock Entry Alerts - Newser
Tandem Diabetes Care Inc. stock daily chart insightsMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Applying Wyckoff theory to Tandem Diabetes Care Inc. stockTrade Analysis Report & Daily Volume Surge Signals - Newser
Published on: 2025-08-31 20:30:16 - Newser
Diabetes warning issued over insulin pump error - MSN
What makes Tandem Diabetes Care Inc. stock price move sharplyJuly 2025 Weekly Recap & Trade Opportunity Analysis - Newser
Measuring Tandem Diabetes Care Inc.’s beta against major indicesPortfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
Unpacking Tandem Diabetes Care's Sharp Intraday Move - AInvest
Tandem Diabetes Care Inc. stock volume spike explained2025 Year in Review & Weekly Top Gainers Alerts - Newser
Tandem Diabetes Care (TNDM.O) Sees Sharp Intraday Move Without Clear Catalyst - AInvest
ATTENTION Tandem Diabetes Care, Inc. (TNDM) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Tandem Diabetes Care Surges 6.1%—Technical Signals Stay Quiet, Volume Rises - AInvest
What data driven models say about Tandem Diabetes Care Inc.’s futureOil Prices & Long-Term Growth Stock Strategies - Newser
Will Tandem Diabetes Care Inc. rebound enough to break evenWeekly Loss Report & Consistent Return Strategy Ideas - Newser
How institutional ownership impacts Tandem Diabetes Care Inc. stockQuarterly Trade Summary & Daily Entry Point Alerts - Newser
How to monitor Tandem Diabetes Care Inc. with trend dashboardsWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Sector ETF performance correlation with Tandem Diabetes Care IncWeekly Volume Report & Weekly High Conviction Ideas - Newser
Price momentum metrics for Tandem Diabetes Care Inc. explainedJuly 2025 Pullbacks & Proven Capital Preservation Tips - Newser
Tandem Diabetes Care Inc Azioni (TNDM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tandem Diabetes Care Inc Azioni (TNDM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
39,376 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '25 |
Option Exercise |
0.00 |
11,453 |
0 |
115,001 |
| Carpenter Rick | Chief Technology Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,335 |
0 |
22,824 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
2,998 |
0 |
36,258 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
3,065 |
0 |
19,102 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
1,795 |
| Sheridan John F | PRESIDENT & CEO |
Aug 11 '25 |
Buy |
10.23 |
10,000 |
102,318 |
106,327 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 08 '25 |
Buy |
10.89 |
13,720 |
149,404 |
25,580 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Jul 15 '25 |
Option Exercise |
0.00 |
14,545 |
0 |
25,254 |
| Carpenter Rick | Chief Technology Officer |
Jun 16 '25 |
Option Exercise |
0.00 |
406 |
0 |
21,426 |
0.38%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):